دورية أكاديمية

Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses

التفاصيل البيبلوغرافية
العنوان: Inactivated whole virion vaccine protects K18‐hACE2 Tg mice against the Omicron SARS‐CoV‐2 variant via cross‐reactive T cells and nonneutralizing antibody responses
المؤلفون: Kruglov, Andrey A., Bondareva, Marina A., Gogoleva, Violetta S., Semin, Iaroslav K., Astrakhantseva, Irina V., Zvartsev, Ruslan, Lunin, Aleksandr S., Apolokhov, Vasiliy D., Shustova, Elena Yu, Volok, Viktor P., Ustyugov, Aleksey A., Ishmukhametov, Aydar A., Nedospasov, Sergei A., Kozlovskaya, Liubov I., Drutskaya, Marina S.
المساهمون: Ministry of Science and Higher Education of the Russian Federation, Russian Science Foundation
المصدر: European Journal of Immunology ; volume 54, issue 3 ; ISSN 0014-2980 1521-4141
بيانات النشر: Wiley
سنة النشر: 2023
المجموعة: Wiley Online Library (Open Access Articles via Crossref)
الوصف: COVID‐19 is a systemic inflammatory disease initiated by SARS‐CoV‐2 virus infection. Multiple vaccines against the Wuhan variant of SARS‐CoV‐2 have been developed including a whole virion beta‐propiolactone‐inactivated vaccine based on the B.1.1 strain (CoviVac). Since most of the population has been vaccinated by targeting the original or early variants of SARS‐CoV‐2, the emergence of novel mutant variants raises concern over possible evasion of vaccine‐induced immune responses. Here, we report on the mechanism of protection by CoviVac, a whole virion‐based vaccine, against the Omicron variant. CoviVac‐immunized K18‐hACE2 Tg mice were protected against both prototype B.1.1 and BA.1‐like (Omicron) variants. Subsequently, vaccinated K18‐hACE2 Tg mice rapidly cleared the infection via cross‐reactive T‐cell responses and cross‐reactive, non‐neutralizing antibodies recognizing the Omicron variant Spike protein. Thus, our data indicate that efficient protection from SARS‐CoV‐2 variants can be achieved by the orchestrated action of cross‐reactive T cells and non‐neutralizing antibodies.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1002/eji.202350664
الإتاحة: https://doi.org/10.1002/eji.202350664Test
حقوق: http://creativecommons.org/licenses/by-nc/4.0Test/
رقم الانضمام: edsbas.C3E88118
قاعدة البيانات: BASE